Financials
- Market Capitalization 1.51 B
- Employee 159
- Founded 1996
- CEO N/A
- Website www.inva.com
- Headquarter Delaware, United States
- FIGI BBG000CG9XT7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
6.06
ratio cours/chiffre d'affaires
4.12
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2178 | LBRX LB Pharmaceuticals Inc - Common Stock | 47.89 USD | -0.58% | +0.38% | +36.28% | +152.05% | 1.54 B USD | ||
| 2181 | AVBP ArriVent BioPharma, Inc. - Common Stock | 31.00 USD | -0.45% | +5.19% | +3.58% | +61.63% | 1.53 B USD | ||
| 2199 | NVAX Novavax, Inc. - Common Stock | 9.05 USD | -1.74% | +7.23% | +24.14% | +19.71% | 1.49 B USD | ||
| 2211 | REPL Replimune Group, Inc. - Common Stock | 15.60 USD | -1.76% | +12.55% | +197.14% | +191.04% | 1.47 B USD |